| United States Patent Application |
20170119767 |
| Kind Code |
A1 |
| Shenoy; Narmada R. |
May 4, 2017 |
PHARMACEUTICAL COMPOSITIONS FOR SUBSTITUTED QUINAZOLINONES
Abstract
The present disclosure relates to novel solid pharmaceutical formulations and process for their preparation. The present disclosure also provides, in part, methods of using the pharmaceutical formulations for regulating the expression of apolipoprotein A-I (ApoA-I), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis.
| Inventors: |
Shenoy; Narmada R.; (Sunnyvale, CA)
|
| Applicant: |
| Name |
City |
State |
Country |
Type |
Resverlogix Corp. |
Calgary |
|
CA |
|
|
| Assignee: |
Resverlogix Corp.
Calgary
CA
|
| Family ID: |
1000002409151 |
| Appl. No.: |
15/408814 |
| Filed: |
January 18, 2017 |
